JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skulan, T. W.
Right arrow Articles by Shideman, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skulan, T. W.
Right arrow Articles by Shideman, F. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 148, Issue 3, 356-362, 1965
Copyright © 1965 by American Society for Pharmacology and Experimental Therapeutics


NATRIURETIC AND ANTIGLYCOGENIC ACTIVITIES OF A SERIES OF SYMMETRICAL TRIAZINE AND PTERIDINE DERIVATIVES

T. W. Skulan 1 and F. E. Shideman 1

1 Department of Pharmacology and Toxicology, University of Wisconsin, Madison, Wisconsin

A series of 24 symmetrical triazine and 3 pteridine derivatives was examined for natriuretic and antiglycogenic activities in the rat. Diuretically active triazines generally produced natriuresis, kaliuresis, and chioruresis, while the renal responses to the pteridine derivatives were not uniform within the group. The two pteridine derivatives possessing natriuretic activity also inhibited the deposition of hepatic glycogen induced by hydrocortisone.

Two triazine derivatives, 2-amino-4-beta-naphthyl-s-triazine and 2-amino-4-(3,4-dimethoxyphenyl) ethylamino-s-triazine, had significantly more antiglycogenic activity relative to natriuretic activity than chiorazanil, while 2-amino-4-pentylamino-s-triazine had significantly less antiglycogenic than natriuretic activity when compared with chlorazanil.

Methyl and ethyl substitution at the 6- position of ehlorazanil abolished its antiglycogenic action. The resultant compounds caused deposition of glycogen in the livers of adrenalectomized rats. Certain of the compounds in which the amino group at the 4-position of the triazine ring was disubstituted also exhibited glycogenic activity. These findings are interpreted as indicating and further supporting the concept that the observed effects of the triazine derivatives on deposition of hepatic glycogen represent rather specific actions of these compounds.

Accepted on February 4, 1965







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1965 by the American Society for Pharmacology and Experimental Therapeutics.